Preoperative Blood Biochemical Testing: Clinical Laboratory Assessment Prior to Surgery

Preoperative blood biochemical testing is a cornerstone of modern surgical preparation, providing quantitative evaluation of hepatic, renal, metabolic, and electrolyte status before anesthesia and operation. This article presents a comprehensive technical overview of preoperative biochemistry panels, including sample requirements, analytical methods, tested parameters, clinical applications, and frequently asked questions. The content is intended for surgeons, anesthesiologists, clinical laboratorians, and healthcare administrators seeking to standardize perioperative laboratory practice.

Technical Overview

Preoperative blood biochemical testing refers to the quantitative laboratory analysis of blood serum or plasma analytes performed prior to a surgical procedure. Its primary purpose is to assess the functional reserve of major organ systems, characterize the metabolic state of the patient, and identify occult abnormalities that may increase perioperative risk. The results directly inform anesthetic planning, fluid and electrolyte management, surgical timing, and postoperative monitoring strategies.

A typical preoperative biochemistry workup evaluates hepatic function, renal function, electrolyte balance, glucose metabolism, and protein status. For most healthy patients undergoing low-risk elective procedures, guidelines increasingly support selective testing based on medical history, physical examination, age, and comorbidities rather than indiscriminate routine screening. For patients with chronic disease, advanced age, or those scheduled for major, high-blood-loss, or emergency surgery, comprehensive biochemical profiling remains standard of care.

Laboratories performing these analyses should operate under a quality management system compliant with ISO 15189 (Medical laboratories — Requirements for quality and competence), with analytical systems calibrated to reference measurement procedures traceable in accordance with ISO 17511. Where specialized or confirmatory testing is required, specimens may be referred to accredited third-party laboratories that meet equivalent international quality standards.

Testing Samples

Serum Samples

Serum is the most common specimen matrix for preoperative biochemistry. Venous blood is collected into plain evacuated tubes or tubes with clot activator, allowed to clot for 20–30 minutes at room temperature, and centrifuged to separate the serum. Serum is suitable for liver function tests, renal function tests, enzymes, proteins, and most metabolic analytes.

Plasma Samples

Plasma obtained from anticoagulated blood (typically lithium heparin) permits faster turnaround because no clotting time is required. Sodium fluoride/potassium oxalate tubes are preferred when precise glucose measurement is needed, since fluoride inhibits glycolysis and stabilizes glucose during transport and storage.

Sample Collection and Handling Requirements

• Fasting collection of 8–12 hours is recommended for glucose, triglycerides, and lipid-adjacent analytes to reduce dietary interference.
• Hemolysis, icterus, and lipemia must be minimized, as they interfere with spectrophotometric assays; grossly hemolyzed specimens should be recollected.
• Correct fill volume and tube order are essential to avoid anticoagulant carryover and EDTA contamination, which falsely lowers potassium and calcium.
• Specimens should be centrifuged promptly and analyzed within the validated stability window; when delayed, serum or plasma should be refrigerated at 2–8 °C.
• Collection, labeling, and transport should follow ISO 20658 requirements for medical laboratory sample pre-examination processes to guarantee integrity and traceability.

Testing Items

Preoperative biochemical panels are typically organized into functional groups selected according to the surgical indication and patient profile:

• Hepatic function panel: alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, direct bilirubin, total protein, and albumin.
• Renal function panel: serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), uric acid, and cystatin C where indicated.
• Electrolyte panel: sodium, potassium, chloride, bicarbonate (total CO2), ionized or total calcium, magnesium, and inorganic phosphorus.
• Glucose and metabolic markers: fasting blood glucose, and glycated hemoglobin (HbA1c) for diabetic patients to confirm perioperative glycemic control.
• Cardiac and muscle markers: creatine kinase (CK), lactate dehydrogenase (LDH), and CK-MB when muscle disease or cardiac risk is suspected.
• Protein and nutritional markers: total protein, albumin, prealbumin, and globulin fractions for nutritional risk assessment before major surgery.

Clinicians may order these analytes as fixed panels (for example, a comprehensive metabolic profile) or as focused profiles such as a liver panel, renal panel, or electrolyte panel, depending on the clinical scenario.

Testing Methods

Preoperative biochemical testing is predominantly performed on automated clinical chemistry analyzers using well-characterized analytical principles:

• UV-visible spectrophotometry with kinetic enzyme assays: the reference technique for ALT, AST, ALP, GGT, CK, and LDH, measuring changes in absorbance of NADH at 340 nm over time.
• Colorimetric endpoint assays: used for total protein (biuret method), albumin (bromocresol green or bromocresol purple), bilirubin (diazo method), creatinine (Jaffe kinetic or enzymatic method), and uric acid.
• Ion-selective electrode (ISE) technology: the standard method for sodium, potassium, chloride, and ionized calcium, available in direct (undiluted) or indirect (diluted) formats.
• Enzymatic methods for glucose: hexokinase or glucose oxidase/peroxidase procedures offering high specificity and traceability.
• Immunoturbidimetric assays: applied to quantification of specific serum proteins such as cystatin C where required.
• Dry chemistry and point-of-care testing (POCT): used for rapid preoperative assessment in urgent settings, with results available within minutes; POCT systems must be governed by the same quality framework as central laboratory analyzers.

Regardless of platform, analytical performance must be verified against established quality specifications, including internal quality control at multiple levels per analytical run and participation in external quality assessment schemes. Result reporting should include age- and sex-specific reference intervals, and critical values (for example, potassium above 6.0 mmol/L or glucose below 2.8 mmol/L) must trigger immediate notification to the surgical team.

Applications

Preoperative blood biochemical testing supports a broad range of clinical decisions across surgical disciplines:

• Anesthesia risk stratification: identifying electrolyte disturbances, renal impairment, or hepatic dysfunction that modify anesthetic drug selection and dosing.
• Elective surgery clearance: documenting baseline organ function before orthopedic, cardiovascular, oncologic, and general surgical procedures.
• Emergency and trauma surgery: rapid assessment of metabolic derangement, acid–base status, and shock-related organ injury to guide resuscitation.
• Chronic disease management: confirming adequate glycemic control in diabetic patients and stable renal function in patients with hypertension or chronic kidney disease before scheduling.
• Geriatric surgery: detecting age-related declines in renal and hepatic reserve that are not apparent on routine examination.
• Major and high-blood-loss surgery: establishing baseline values for intraoperative and postoperative trending of hemoglobin-adjacent markers, electrolytes, and organ function.
• Transplant and bariatric programs: comprehensive metabolic evaluation as part of structured preoperative candidacy protocols.
• Baseline documentation: providing reference values that enable early detection of postoperative complications such as acute kidney injury or hepatocellular injury.

FAQ

Is preoperative blood biochemical testing mandatory for every patient?

No. Current evidence favors a selective testing strategy. Healthy patients undergoing low-risk, minimally invasive procedures often do not require routine biochemistry. Testing is indicated when the medical history, physical examination, age, medication use, comorbidities, or the nature of the surgery suggests a reasonable probability of abnormal results that would change management.

How long before surgery should the tests be performed?

For elective surgery in stable patients, biochemistry results obtained within 30 days before the operation are generally considered valid. For patients with unstable chronic disease, substantial medication changes, or serious illness, testing within 48–72 hours (or on the day of surgery) is recommended.

Can abnormal results delay or cancel surgery?

Certain critical abnormalities — severe hyperkalemia, uncontrolled hyperglycemia, acute kidney injury, or significant hepatic dysfunction — may prompt postponement until the condition is corrected, because they substantially increase perioperative morbidity. Minor deviations are usually managed with perioperative precautions rather than cancellation.

What is the typical turnaround time?

Automated chemistry analyzers in accredited laboratories typically report routine preoperative panels within 1–4 hours of sample receipt. Point-of-care systems can deliver electrolyte and glucose results in under 15 minutes for urgent cases.

Do medications interfere with the results?

Yes. Diuretics, ACE inhibitors, angiotensin receptor blockers, metformin, statins, and numerous other agents can alter electrolytes, glucose, and enzyme results. The surgical team should review all medications and, where appropriate, time blood collection relative to dosing to ensure interpretable results.

How is quality assured in preoperative biochemistry testing?

Quality is ensured through ISO 15189-compliant laboratory accreditation, validated analytical systems, multi-level internal quality control, external quality assessment participation, traceable calibration materials, and documented critical-value notification procedures. Independent verification and confirmatory testing can be obtained from accredited third-party laboratories when required.